Novartis Australia responds to pandemic challenges faced by patient organisations

Novartis is responding to the challenges faced by patient organisations with the announcement of three key initiatives to help them continue their critical work throughout the COVID-19 crisis.

hcq trial hero image

Novartis to assist Australian Government with initial supply of hydroxychloroquine

Novartis Australia, and its generics and biosimilars division Sandoz, has confirmed that it will be working with the Australian government to provide an initial supply of generic hydroxychloroquine to support the COVID-19 pandemic response.

Illustration: Coronavirus (Centers for Disease Control and Prevention)

Coronavirus (COVID-19) Novartis Australia & New Zealand

Novartis in Australia and New Zealand continues to closely monitor and respond to the coronavirus (COVID-19) situation. Our priority is to ensure the health and safety of our people, patients, and healthcare professionals.

Novartis working from home